معرفی
Dr. Quentin Faucher is a Research Fellow in Pharmacology at the Faculty of Science, Utrecht University, Netherlands. He works within the Division of Pharmacology at the Utrecht Institute for Pharmaceutical Sciences, where he conducts innovative research at the intersection of kidney and brain physiology. Faucher is a member of the Brain-on-chip and Kidney-on-chip theme groups at HDMT and holds a prestigious Marie Sklodowska-Curie Action Postdoctoral Fellowship awarded in February 2023.
Dr. Faucher earned his PhD in Pharmacology, Infectious diseases and Drug Science from Limoges University, France. His doctoral research was conducted at the INSERM U1248 Pharmacology and Transplantation unit, focusing on translational studies of ischemia-reperfusion effects on tubular transport systems in kidney transplantation.
His primary research interests center on the kidney-brain axis, particularly investigating how chronic kidney disease leads to neurological complications through uremic toxin accumulation. Faucher specializes in developing multi-organs-on-chip models to study kidney-brain crosstalk, with emphasis on blood-brain barrier dysfunction in uremic syndrome. His work integrates pharmacology, metabolomics, and organ-on-chip technology to understand disease mechanisms and develop potential therapeutic approaches.
Analysis of Dr. Faucher's publication record reveals a strong focus on kidney physiology, drug transporters, and the molecular mechanisms of kidney disease. His research spans from fundamental studies of organic anion transporters to clinical applications in transplantation and chronic kidney disease. Recent work shows increasing emphasis on organ-on-chip technology and the neurological complications of kidney disease, reflecting his current Marie Curie fellowship project.
- Marie Sklodowska-Curie Action Postdoctoral Fellowship (2023)
Dr. Faucher's research is supported by his Marie Sklodowska-Curie Action Postdoctoral Fellowship from the European Research Executive Agency. While specific students aren't listed in the available information, his position as a postdoctoral researcher suggests he likely collaborates with PhD students and junior researchers within the Utrecht Institute for Pharmaceutical Sciences. His work involves significant interdisciplinary collaboration across pharmacology, nephrology, and neuroscience domains.
As a member of the Brain-on-chip and Kidney-on-chip theme groups at HDMT, Dr. Faucher works within a cutting-edge research environment focused on developing and applying organ-on-chip technology. His current project involves engineering a miniature kidney-brain axis model to unravel neuropathies associated with chronic kidney disease, representing a novel approach to studying systemic disease effects through integrated microphysiological systems.
